Page last updated: 2024-11-02

pioglitazone and Enterocolitis, Pseudomembranous

pioglitazone has been researched along with Enterocolitis, Pseudomembranous in 1 studies

Pioglitazone: A thiazolidinedione and PPAR GAMMA agonist that is used in the treatment of TYPE 2 DIABETES MELLITUS.
pioglitazone : A member of the class of thiazolidenediones that is 1,3-thiazolidine-2,4-dione substituted by a benzyl group at position 5 which in turn is substituted by a 2-(5-ethylpyridin-2-yl)ethoxy group at position 4 of the phenyl ring. It exhibits hypoglycemic activity.

Enterocolitis, Pseudomembranous: An acute inflammation of the INTESTINAL MUCOSA that is characterized by the presence of pseudomembranes or plaques in the SMALL INTESTINE (pseudomembranous enteritis) and the LARGE INTESTINE (pseudomembranous colitis). It is commonly associated with antibiotic therapy and CLOSTRIDIUM DIFFICILE colonization.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Viladomiu, M1
Hontecillas, R1
Pedragosa, M1
Carbo, A1
Hoops, S1
Michalak, P1
Michalak, K1
Guerrant, RL1
Roche, JK1
Warren, CA1
Bassaganya-Riera, J1

Other Studies

1 other study available for pioglitazone and Enterocolitis, Pseudomembranous

ArticleYear
Modeling the role of peroxisome proliferator-activated receptor γ and microRNA-146 in mucosal immune responses to Clostridium difficile.
    PloS one, 2012, Volume: 7, Issue:10

    Topics: Analysis of Variance; Animals; Base Sequence; Clostridioides difficile; Colon; DNA Primers; Enteroco

2012